MANNKIND CORP Money Market Funds, at Carrying Value
MANNKIND CORP (MNKD) had Money Market Funds, at Carrying Value of $41.00 million as of 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Notes
us-gaap:MoneyMarketFundsAtCarryingValue · last filed 2018-02-27
- 2017-12-31: Money Market Funds, at Carrying Value $41.00M.
- 2017-09-30: Money Market Funds, at Carrying Value $18.40M.
- 2017-06-30: Money Market Funds, at Carrying Value $42.10M.
- 2017-03-31: Money Market Funds, at Carrying Value $47.40M.
| Period end | Money Market Funds, at Carrying Value |
|---|---|
| 2017-12-31 | $41.00M 10-K · filed 2018-02-27 |
| 2017-09-30 | $18.40M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $42.10M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $47.40M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $20.50M 10-K · filed 2018-02-27 |
| 2016-09-30 | $33.70M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $56.80M 10-Q/A · filed 2016-08-10 |
| 2016-03-31 | $26.00M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $55.80M 10-K · filed 2017-03-16 |
| 2015-09-30 | $32.90M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $104.70M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $120.50M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $118.50M 10-K · filed 2016-03-15 |
| 2014-09-30 | $169.70M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $41.10M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $34.90M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $67.70M 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |